← Browse by Condition
Medical Condition

cerebral small vessel disease

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06674460 Phase 3
Recruiting

Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease

Enrollment
600 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →
NCT06643013
Recruiting

Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease

Enrollment
106 pts
Location
United Kingdom
Sponsor
Imperial College London
View Trial →